Compared to the E2 group (50 μg/kg/day, six times a week), which increased TC, TG levels and expression of tumor markers, the ECH treatment groups displays improved lipid parameters and reduced tumor markers CA-125 and CEA expression. This evidence concerns the gene MUC16 and neoplasm.